Industry news
This entire item is of approximately 350 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the September 2008 issue of Biomedical Materials and download it online

  • Issue: September 2008, page: 4

    ReGen Biologics raises funds, seeks approval for scaffold

    Orthopaedics company ReGen Biologics Inc said it completed a US$2.5 million private placement of convertible notes and at the same time, submitted a new 510(k) application seeking clearance from the US Food and Drug Administration (FDA) of its collagen scaffold for reinforcement and repair of meniscus tissue.

    Read related items on:

          
  • Medical
  • Menaflex
  • Financial
  • ReGen Biologics
  • US Food and Drug Administration

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact